Search for: "Deas v. Deas" Results 161 - 180 of 821
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Mar 2019, 9:00 am by Staff
Subsequent to the FDA approval of Epidiolox, The Drug Enforcement Administration (DEA) issued a Final Order placing “FDA-approved drugs that contain CBD derived from cannabis and no more than 0.1 percent tetrahydrocannabinols” [such as Epidiolox] in Schedule V of the Controlled Substances Act,”  “Schedule V drugs are considered to have the lowest potential for abuse compared to other scheduled drugs and a low potential for psychological or… [read post]
4 Mar 2019, 6:56 am by Second Circuit Civil Rights Blog
This is due process.The Eighth Circuit had a case like this more than 20 years ago, Madewell v. [read post]
13 Feb 2019, 11:53 am
Schedule V Substances: Schedule V drugs are considered potentially dangerous drugs with a low potential for abuse and which contain limited quantities of narcotics. [read post]
20 Nov 2018, 10:07 am by Phil Dixon
The Drug Enforcement Agency (“DEA”) also recently reclassified some CBD products as Schedule V controlled substances, apparently to allow Epidiolex (mentioned above) onto the market. [read post]
20 Oct 2018, 6:07 am by Anushka Limaye
In other Supreme Court news, Peter Margulies assessed the oral arguments in Sessions v. [read post]
5 Oct 2018, 3:00 am by Christopher Tyner
  The Greensboro News & Record reports that the North Carolina Supreme Court’s reversal of State v. [read post]